Chinese Journal of Antituberculosis ›› 2018, Vol. 40 ›› Issue (12): 1330-1334.doi: 10.3969/j.issn.1000-6621.2018.12.017
• Original Articles • Previous Articles Next Articles
LIN Shu-fang(),WEI Shu-zhen,ZHAO Yong,LIN Jian,LIN Yong-ming.
Received:
2018-07-26
Online:
2018-12-10
Published:
2018-12-10
LIN Shu-fang,WEI Shu-zhen,ZHAO Yong,LIN Jian,LIN Yong-ming.. Phenotypic pyrazinamide resistance and genotypic characteristics among multidrug-resistant Mycobacterium tuberculosis isolates in Fujian Province[J]. Chinese Journal of Antituberculosis, 2018, 40(12): 1330-1334. doi: 10.3969/j.issn.1000-6621.2018.12.017
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2018.12.017
[1] |
Ibrahim M, Andries K, Lounis N , et al. Synergistic activity of R207910 combined with pyrazinamide against murine tuberculosis. Antimicrob Agents Chemother, 2007,51(3):1011-1015.
doi: 10.1128/AAC.00898-06 URL pmid: 17178794 |
[2] |
Tasneen R, Tyagi S, Williams K , et al. Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis. Antimicrob Agents Chemother, 2008,52(10):3664-3668.
doi: 10.1016/S0167-8655(00)00032-5 URL pmid: 18694943 |
[3] |
Diacon AH, Donald PR, Pym A , et al. Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance. Antimicrob Agents Chemother, 2012,56(6):3271-3276.
doi: 10.1128/AAC.06126-11 URL pmid: 22391540 |
[4] |
Whitfield MG, Soeters HM, Warren RM , et al. A global perspective on pyrazinamide resistance: systematic review and meta-analysis. PLoS One, 2015,10(7):e0133869.
doi: 10.1371/journal.pone.0133869 URL pmid: 4517823 |
[5] |
Kam KM, Yip CW, Tse LW , et al. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J Clin Microbiol, 2005,43(1):306-313.
doi: 10.1128/JCM.43.1.306-313.2005 URL pmid: 15634987 |
[6] | Lillebaek T, Andersen AB, Dirksen A , et al. Mycobacterium tuberculosis Beijing genotype. Emerg Infect Dis, 2003,9(12):1553-1557. |
[7] | Glynn JR, Whiteley J, Bifani PJ , et al. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis, 2002,8(8):843-849. |
[8] | Gori A, Bandera A, Marchetti G , et al. Spoligotyping and Mycobacterium tuberculosis. Emerg Infect Dis, 2005,11(8):1242-1248. |
[9] | World Health Organization , International Union Against Tuberculosis and Lung Diseases. Guidelines for surveillance of drug resistance in tuberculosis. Geneva: World Health Organi-zation, 1997. |
[10] |
World Health Organization . Policy guidance on drug susceptibility testing (DST) of second line antituberculosis drug. Geneva: World Health Organization, 2008: 11.
URL pmid: 26290924 |
[11] |
Viana-Niero C, Gutierrez C, Sola C , et al. Genetic diversity of Mycobacterium africanum clinical isolates based on IS6110-restriction fragment length polymorphiSm analysis, spoligotyping, and variable number of tandem DNA repeats. J Clin Microbiol, 2001,39(1):57-65.
doi: 10.1128/JCM.39.1.57-65.2001 URL pmid: 87680 |
[12] |
Brudey K, Driscoll JR, Rigouts L , et al. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol, 2006,6:23.
doi: 10.1186/1471-2180-6-23 URL pmid: 1468417 |
[13] | Weniger T, Krawczyk J, Supply P , et al. MIRU-VNTRplus: a web tool for polyphasic genotyping of Mycobacterium tuberculosis complex bacteria. Nucleic Acids Res, 2010,38(Web Server issue):W326-W331. |
[14] | Xu P, Wu J, Yang C , et al. Prevalence and transmission of pyrazinamide resistant Mycobacterium tuberculosis in China. Tuberculosis (Edinb), 2016,98:56-61. |
[15] |
Kurbatova EV, Cavanaugh JS, Dalton T , et al. Epidemiology of pyrazinamide-resistant tuberculosis in the United States, 1999—2009. Clin Infect Dis, 2013,57(8):1081-1093.
doi: 10.1093/cid/cit452 URL pmid: 4578633 |
[16] |
Gu Y, Yu X, Jiang G , et al. Pyrazinamide resistance among multidrug-resistant tuberculosis clinical isolates in a national referral center of China and its correlations with pncA, rpsA, and panD gene mutations. Diagn Microbiol Infect Dis, 2016,84(3):207-211.
doi: 10.1016/j.diagmicrobio.2015.10.017 URL pmid: 26775806 |
[17] |
Pang Y, Zhu D, Zheng H , et al. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. BMC Infect Dis, 2017,17(1):711.
doi: 10.1186/s12879-017-2761-6 URL pmid: 29110640 |
[18] | Alame-Emane AK, Xu P, Pierre-Audigier C , et al. Pyrazinamide resistance in Mycobacterium tuberculosis arises after rifa-mpicin and fluoroquinolone resistance. Int J Tuberc Lung Dis, 2015,19(6):679-684. |
[19] | 周银发, 张山鹰, 魏淑贞 , 等. 福建省耐多药结核分枝杆菌对吡嗪酰胺耐药性的研究. 结核病与肺部健康杂志, 2018,7(2):123-127. |
[20] |
梁庆福, 郑金凤, 陈求扬 , 等. 218例涂阳肺结核吡嗪酰胺耐药情况分析. 中国人兽共患病学报, 2012,28(10):1000-1002.
doi: 10.3969/cjz.j.issn.1002-2694.2012.10.008 URL |
[21] | Han SJ, Song T, Cho YJ , et al. Complete genome sequence of Mycobacterium tuberculosis K from a Korean high school outbreak, belonging to the Beijing family. Stand Genomic Sci, 2015,10:78. |
[22] | Maeda S, Wada T, Iwamoto T , et al. Beijing family Mycobacterium tuberculosis isolated from throughout Japan: phylogeny and genetic features. Int J Tuberc Lung Dis, 2010,14(9):1201-1204. |
[23] |
刘飞鹰, 刘志广, 王喜文 , 等. Spoligotyping对广西地区208株结核分枝杆菌临床分离株的基因分型. 中国人兽共患病学报, 2007,23(12):1226-1230.
doi: 10.3969/j.issn.1002-2694.2007.12.015 URL |
[24] |
王晓萌, 吕冰, 柳正卫 , 等. Spoligotyping和MLVA用于71株浙江省结核分枝杆菌临床分离株基因分型的初步研究. 中国人兽共患病学报, 2008,24(12):1090-1094.
doi: 10.3969/j.issn.1002-2694.2008.12.002 URL |
[25] | Li Y, Cao X, Li S , et al. Characterization of Mycobacterium tuberculosis isolates from Hebei, China: genotypes and drug susceptibility phenotypes. BMC Infect Dis, 2016,16:107. |
[26] |
逄宇, 夏辉, 姜广路 , 等. 中国结核分枝杆菌寡核苷酸基因分型及其耐药性分析. 中华检验医学杂志, 2011,34(11):1023-1028.
doi: 10.3760/cma.j.issn.1009-9158.2011.11.014 URL |
[27] |
王胜芬, 赵雁林, 黄海荣 , 等. 结核分枝杆菌北京基因型菌株与耐药表型的关系. 中国医学科学院学报, 2009,31(4):427-431.
doi: 10.3881/j.issn.1000-503X.2009.04.009 URL |
[1] | LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008. |
[2] | Academic Working Committee of Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis . Expert consensus of clinical application of fixed-dose combination formulations [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 885-893. |
[3] | JIN Hong-jian. The construction of tuberculosis prevention and control service system at county level in China needs to be strengthened urgently —— Comments and suggestions of an old tuberculosis control and prevention worker [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 896-902. |
[4] | ZHANG Can-you, XIA Hui, CHENG Jun. Testing and reporting requirements for Class Ⅱ biosafety cabinet in tuberculosis laboratory [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 903-909. |
[5] | ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915. |
[6] | LIU Er-yong, WANG Qian, ZHOU Lin, ZHANG Guo-qin, ZHANG Xiu-lei, MA Yong-cheng, YANG Shu-min, WANG Cui, MENG Qing-lin, CHEN Ming-ting, LIN Ming-gui, TU De-hua.. Analysis of diagnostic quality of pulmonary tuberculosis with negative etiology in some areas of China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 916-920. |
[7] | MENG Qing-lin, LI Jin-lan, LIN Ding-wen, MA Yong-cheng, HOU Shuang-yi, LIU Nian-qiang, ZHOU Lin. Analysis of the awareness about knowledge on the updated TB diagnosis standard among the practitioners in TB control institutions [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 921-925. |
[8] | WANG Qian, ZHOU Lin, LIU Er-yong, ZHAO Yan-lin, LI Tao, CHEN Ming-ting, YANG Li-jia, WANG Jia.. A survey on the diagnostic ability of tuberculosis in the county-level medical institutions in China [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 926-930. |
[9] | LI Ting, HE Jin-ge, SU Qian, LI Jing, LI Yun-kui, GAO Wen-feng, GAO Yuan, YANG Wen. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 931-936. |
[10] | LI Yun-kui, HE Jin-ge, SU Qian, LI Ting, LI Jing, GAO Wen-feng, YANG Wen, MAO Guang-yu. Value of tuberculin test in screening tuberculosis infection in HIV infected/AIDS patients in Butuo County, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 937-941. |
[11] | SU Qian, XIA Yong, LU Jia, WANG Dan-xia, HE Jin-ge. Analysis on the epidemiological characteristics of pulmonary tuberculosis among children aged 0-14 in Sichuan Province from 2009 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 942-947. |
[12] | DENG Ya-li, ZHANG Tian-hua, LIU Wei-ping, ZHANG Hong-wei, MA Yu, LI Peng.. Temporal and spatial clustering analysis of pulmonary tuberculosis incidence in Shaanxi Province from 2014 to 2018 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 948-955. |
[13] | DONG Xiao, ZHAO Zhen, LIU Nian-qiang, WANG Sen-lu, CUI Yan. Analysis of the finding characteristics of pulmonary tuberculosis in the elderly population in Xinjiang Uygur Autonomous Region during 2009—2017 [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 956-961. |
[14] | MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972. |
[15] | NAN Hai, ZHANG Yun, YANG Xin-ting, DUAN Hong-fei. Meta-analysis on the diagnostic value of GeneXpert MTB/RIF for bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 973-980. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||